PAREXEL International advances healthcare discoveries by sharing its expertise in drug development, regulatory consulting, clinical research, medical communications and enabling technologies to the biopharmaceutical and medical device industries worldwide.
Our expertise spans many therapeutic areas with extensive experience in Oncology, Cardiology, CNS and Infectious Disease. We work with the top ten biotechnology and top 20 pharmaceutical companies. Additionally, we have also used our extensive experience to assist hundreds of small and emerging bio/pharmaceutical companies in reaching their milestones.
Phase I-IV studies
PAREXEL is a proven and committed partner to drug developers and medical device manufacturers looking to bring innovative new products to market. Our Phase I-IV studies incorporate the full range of services from First in Man and Proof of Concept studies to clinical study design to bioanalytics to peri-approval and post-marketing services. This expertise is enhanced by advanced technology solutions, including medical imaging, clinical trial management systems (CTMS), interactive voice response (IVRS), and integration services. We have decades of experience, deep expertise, and the global resources required to handle studies-and programs of studies-of any size, anywhere in the world. Headquartered near Boston, Massachusetts, PAREXEL operated in 71 locations throughout 50 countries around the world.
195 West Street
Waltham, Ma. 02451
Tel: +1 781 487 9900
Fax: +1 781 487 0525